{
    "title": "105_hr3946",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``ICCVAM Authorization Act of 1998''.\n\nSEC. 2. INTERAGENCY COORDINATING COMMITTEE ON THE VALIDATION OF \n              ALTERNATIVE METHODS.\n\n    (a) In General.--The Interagency Coordinating Committee on the \nValidation of Alternative Methods (referred to in this Act as \n``ICCVAM'') shall be sustained as a permanent standing committee and \ncontinued to be administered by the National Institute of Environmental \nHealth Sciences. The purposes of ICCVAM shall be to--\n            (1) increase the efficiency and effectiveness of Federal \n        agency test method review;\n            (2) eliminate duplicative efforts and share experiences \n        across Federal regulatory agencies;\n            (3) optimize utilization of scientific expertise outside \n        the Federal Government;\n            (4) ensure that new test methods meet the needs of Federal \n        agencies; and\n            (5) reduce, refine, and replace the use of animals in \n        testing.\n    (b) Composition.--ICCVAM shall be comprised of a representative \nfrom each of the following agencies and organizations:\n            (1) Agency for Toxic Substances and Disease Registry.\n            (2) Consumer Product Safety Commission.\n            (3) Department of Agriculture.\n            (4) Department of Defense.\n            (5) Department of Energy.\n            (6) Department of the Interior.\n            (7) Department of Transportation.\n            (8) Environmental Protection Agency.\n            (9) Food and Drug Administration.\n            (10) National Institute for Occupational Safety and Health.\n            (11) National Institutes of Health.\n            (12) National Cancer Institute.\n            (13) National Institute of Environmental Health Sciences.\n            (14) National Library of Medicine.\n            (15) Occupational Safety and Health Administration.\n            (16) Any other agency that develops, employs, or regulates \n        the use of animals in toxicity testing.\n    (c) Scientific Advisory Committee.--\n            (1) Establishment.--In addition, the National Institute of \n        Environmental Health Sciences shall establish a Scientific \n        Advisory Committee to assist ICCVAM and the National Institute \n        of Environmental Health Sciences. The Committee shall be \n        composed of at least one knowledgeable representative having a \n        history of expertise, development, or evaluation in \n        alternatives to animal toxicological tests, from each of the \n        following interests:\n                    (A) The personal care, pharmaceutical, industrial \n                chemicals, agriculture, and any other regulated \n                industry.\n                    (B) A national animal protection organization \n                established under section 501(c)(3) of the Internal \n                Revenue Code of 1986.\n            (2) Membership.-- The National Institute of Environmental \n        Health Sciences shall also invite to be members of the \n        Scientific Advisory Committee representatives from other \n        stakeholder organizations such as:\n                    (A) An academic institution.\n                    (B) A State government agency.\n                    (C) An international regulatory body.\n                    (D) A corporation developing or marketing \n                alternative test methodologies including contract \n                laboratories.\n    (d) Duties.--ICCVAM shall carry out the following duties consistent \nwith the protection of public health and the environment and for the \npurpose of reducing, refining, and replacing the use of animals in \nacute and chronic toxicological tests:\n            (1) Review and evaluate existing and new alternative \n        methods, including batteries of tests and test screens, which \n        may be acceptable for specific regulatory uses, including the \n        coordination of technical reviews of proposed new or revised \n        test methods of interagency interest.\n            (2) Facilitate interagency and international harmonization \n        of acute chronic toxicological test protocols that encourage \n        the reduction, refinement, or replacement of animal tests.\n            (3) Facilitate, promote, and provide guidance on \n        development of validation criteria and processes for new \n        methods and help promote the acceptance of such methods and \n        awareness of accepted methods by Federal agencies and other \n        stakeholders.\n            (4) File formal recommendations with each appropriate \n        Federal agency identifying specific agency guidelines, \n        recommendations, or regulations for each new test, battery of \n        tests, test screen, or end point reviewed by ICCVAM that may be \n        appropriate for the reduction, refinement, or replacement of an \n        animal test required or recommended by that Federal agency for \n        compliance with that agency's specific statutes, regulations, \n        or guidelines. Tests may be recommended for a certain class of \n        chemicals within that regulatory framework.\n            (5) Consider for review and evaluation, petitions received \n        from the public which identify a specific regulation, \n        recommendation, or guideline, and which recommend alternatives \n        and provide scientific evidence of the acceptability of the \n        alternatives for the purpose of carrying out the regulatory \n        mandate in question.\n            (6) Make final recommendations to agencies and responses \n        from agencies available to the public.\n            (7) Make an annual report to be made available to the \n        public on its progress to promote the regulatory acceptance of \n        new and revised toxicological tests.\n\nSEC. 3. APPLICATION.\n\n    This Act shall not apply to regulations, guidelines, or \nrecommendations related to medical research. The term ``medical \nresearch'' means research, including research performed using \nbiotechnology, related to the causes, diagnosis, treatment, or control \nof physical or mental impairments of humans or animals. The term does \nnot include the testing of a product to determine its toxicity for the \npurpose of complying with protocols, recommendations, or guidelines for \ntesting required, recommended, or accepted by a Federal regulatory \nagency for a product introduced in commerce.\n\nSEC. 4. FEDERAL AGENCY ACTION.\n\n    (a) Identification of Tests.--Within 180 days after the date of \nenactment of this Act, each Federal agency authorized to carry out a \nregulatory program which requires or recommends acute or chronic \ntoxicological testing shall identify any regulation or industry-wide \nguideline which specifically, or in practice requires, recommends, or \nencourages the use of an animal acute or chronic toxicological test and \nshall forward to ICCVAM a list of these regulations, guidelines, and \nrecommendations along with the test or tests recommended or required.\n    (b) Alternatives.--Each Federal agency shall promote and encourage \nthe development and use of alternatives to animal tests, including \nbatteries of tests and test screens, where appropriate, for the purpose \nof complying with Federal regulations, guidelines, or recommendations, \nin each instance, and for each chemical class, for which such tests are \nfound to be effective for generating data at least equivalent for \nhazard identification or dose-response assessment purposes to the \nmethod established under the current regulatory scheme.\n    (c) Test Validation.--Each Federal agency shall ensure that any new \nacute or chronic toxicity test, including animal tests and \nalternatives, is determined to be valid for its proposed use prior to \nrequiring, recommending, or encouraging its application.\n    (d) Reviews.--Each Federal agency shall review any formal \nrecommendations from ICCVAM to promulgate new regulations or draft new \nguidelines or recommendations to promote the ICCVAM recommendations and \nnotify ICCVAM in writing of its findings within 180 days of receipt of \nthe recommendations.\n    (e) Recommendation Adoption.--Each Federal agency shall adopt the \nICCVAM recommendations unless it determines that--\n            (1) the alternative is not adequate in terms of biological \n        relevance for the regulatory goal authorized by the agency;\n            (2) the alternative does not generate data at least \n        equivalent for the appropriate hazard identification or dose-\n        response assessment purpose as the method recommended by the \n        agency;\n            (3) the agency does not employ, recommend, or require \n        testing for that class of chemical or for the recommended end \n        point; or\n            (4) each government agency retains fully the prerogative of \n        deciding whether the new test method is acceptable for \n        satisfactorily fulfilling the test needs for their particular \n        agency and its respective congressional mandate."
}